Alex Prokopienko
Director, Clinical Science at Blueprint Medicines
- Role
- Director, Clinical Science at Blueprint Medicines
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Alex Prokopienko
High-performing leader with clinical, scientific and diplomatic skillsets. Seven years of early to late-stage clinical development experience in immunology, allergy, rare disease, gastroenterology, pulmonary and neurology. Matrix-leadership experience that includes leading pivotal phase 3, first-in-human, hepatic impairment, bioavailability or bioequivalence, food effect, drug-drug interaction, oral contraceptive, ADME, and proof of concept studies. Additional experience with AdComm preparation, regulatory filings (BLA (e.g, Entyvio), s/NDA (Eohilia and Orkambi), and INDs) and pediatric development.Team-player with experience presenting to C-suite executives for high priority due diligence projects including 6-billion-dollar acquisition of zasocitinib and other clinical programs.Strategic clinical scientist with a record of achievement with 17 published manuscripts and NIH funding.Founding Director of the Takeda Clinical Sciences PharmD/PhD Fellowship.Views are my own and do not represent Blueprint Medicines
Experience
Director, Clinical Science
Mar 2025 — Present · Cambridge, MA, US
Clinical Science lead for mast cell activation syndrome (MCAS) Proof of Concept study with BLU-808
Education
University of Pittsburgh
Doctor of Philosophy (PhD), Clinical Pharmaceutical Sciences
Albany College of Pharmacy and Health Sciences
Doctor of Pharmacy (PharmD)
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.